Tech Company Financing Transactions
Antegrin Therapeutics Funding Round
Private investors participated in a $250 thousand venture round for Antegrin Therapeutics. The round was recorded on 12/31/2014.
Transaction Overview
Company Name
Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$250,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4320 Forest Park Ave. 304
St. Louis, MO 63108
USA
St. Louis, MO 63108
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Antegrin Therapeutics is a pharmaceutical company dedicated to the development of novel therapies for fibrotic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Karr
Chief Scientific Officer
Peter Ruminski
Co-Founder
David Griggs
Browse more venture capital transactions:
Prev: 12/31/2014: Electronic Drug Information Systems Solutions venture capital transaction
Next: 12/31/2014: NeoPad Technologies venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs